Powered by smart SET™, the Pattern Recognition Capability Analyzes Continuous Patient Data to Provide Clinicians With Earlier Insight Into Opioid-Related Respiratory Risk
Revvity has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
WASHINGTON , June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation,...
NEW YORK , June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday,...
At ASMS, SCIEX , a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new...
At ASMS, SCIEX , a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for...
/Thermo%20Fisher%20Scientific%20Inc_%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
/Danaher%20Corp_%20logo%20on%20vial-by%20Melnilov%20Dmitriy%20via%20Shutterstock.jpg)
Danaher has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.